Cemented vs Cementless Knee Implants for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial evaluates two types of knee implants to determine which is safer and more effective for people with osteoarthritis. The focus is on comparing cemented and cementless knee implants. Individuals with osteoarthritis considering knee replacement surgery may be suitable candidates, especially if their doctor has recommended one of these implant types. As an unphased trial, this study provides patients the opportunity to contribute to valuable research that could enhance future knee replacement options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that these knee implant systems are safe for osteoarthritis?
Research has shown that both the cemented and cementless Persona knee implants are generally safe. Studies have found that these implants last a long time and improve patient well-being over several years. Specifically, patients with the cemented Persona knee system reported positive results up to two years post-surgery, experiencing better function and implant performance.
The cementless Persona knee system is designed to connect securely with the bone, and research has demonstrated its safety and effectiveness. Both types of implants have undergone testing in other studies and are well-tolerated by patients. No major safety concerns have been reported for either type of implant in these studies.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for knee osteoarthritis because they explore the benefits of two different implant techniques: cemented and cementless knee implants. Unlike traditional cemented implants, which use bone cement to secure the joint, the cementless option encourages natural bone growth to anchor the implant. This natural integration can potentially lead to a more stable and longer-lasting joint replacement. These innovations could offer patients more tailored options, improving overall outcomes and satisfaction.
What evidence suggests that this trial's treatments could be effective for osteoarthritis?
This trial will compare the Cemented Persona Keel Knee System with the Cementless Persona Keel Knee System for patients with osteoarthritis. Studies have shown that both cemented and cementless knee implants, such as the Persona Knee systems, are safe and effective. Specifically, research found that the cemented Persona Knee System had a 97.0% success rate at two years, indicating that the implants remained in place and functioned well for most patients. Studies also show that the cementless Persona Knee provides stable support, which can enhance knee function over time. Both types of implants generally yield good results for patients with osteoarthritis, improving knee function and reducing pain.14678
Are You a Good Fit for This Trial?
This trial is for adults with various knee conditions like arthritis or deformities who need a total knee replacement. Participants must be able to follow the study's procedures and give informed consent. Pregnant individuals, those in other studies, or with mental/neurologic conditions that affect postoperative care are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Evaluation
Participants undergo preoperative clinical evaluations prior to their total knee arthroplasty
Treatment
Participants receive either the Persona OsseoTi Keel Cementless System or the Persona Keel Cemented System during surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment with follow-up clinic visits
What Are the Treatments Tested in This Trial?
Interventions
- Cemented Persona Knee System
- Cementless Persona Knee System
Cemented Persona Knee System is already approved in United States for the following indications:
- Rheumatoid arthritis
- Osteoarthritis
- Traumatic arthritis
- Polyarthritis
- Collagen disorders
- Avascular necrosis of the femoral condyle
- Post-traumatic loss of joint configuration
- Patellofemoral erosion, dysfunction or prior patellectomy
- Moderate valgus, varus, or flexion deformities
- Salvage of previously failed surgical attempts
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zimmer Biomet
Lead Sponsor
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business